| 1 |
34800879 | Novel combination therapy of prostate cancer cells with arsenic trioxide and flutamide: An in-vitro study. | 2022 Feb |
1 |
| 2 |
35366048 | Combined anticancer effects of simvastatin and arsenic trioxide on prostate cancer cell lines via downregulation of the VEGF and OPN isoforms genes. | 2022 May |
2 |
| 3 |
35487055 | Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach. | 2022 Jun |
1 |
| 4 |
33982781 | Arsenic trioxide-loaded CalliSpheres: In vitro study of drug release and antitumor activity, and in vivo study of pharmacokinetics, treatment efficacy and safety in liver cancer. | 2021 Jul |
1 |
| 5 |
34383201 | Hypoxic Hepatocellular Carcinoma Cells Acquire Arsenic Trioxide Resistance by Upregulating HIF-1α Expression. | 2021 Aug 12 |
4 |
| 6 |
34776969 | Angiogenesis is Inhibited by Arsenic Trioxide Through Downregulation of the CircHIPK3/miR-149-5p/FOXO1/VEGF Functional Module in Rheumatoid Arthritis. | 2021 |
9 |
| 7 |
29699374 | Inhibitory Effects of Arsenic Trioxide and Thalidomide on Angiogenesis and Vascular Endothelial Growth Factor Expression in Leukemia Cells | 2018 Apr 27 |
1 |
| 8 |
30014256 | Low dosage of arsenic trioxide (As2O3) inhibits angiogenesis in epithelial ovarian cancer without cell apoptosis. | 2018 Aug |
5 |
| 9 |
30477221 | Arsenic Trioxide Suppressed Migration and Angiogenesis by Targeting FOXO3a in Gastric Cancer Cells. | 2018 Nov 24 |
2 |
| 10 |
28670885 | Anti-Vascular Endothelial Growth Factor Effects of Sorafenib and Arsenic Trioxide in Acute Myeloid Leukemia Cell Lines | 2017 Jun 25 |
1 |
| 11 |
29088724 | Inhibition of angiogenesis by arsenic trioxide via TSP-1-TGF-β1-CTGF-VEGF functional module in rheumatoid arthritis. | 2017 Sep 26 |
3 |
| 12 |
25728215 | Environmentally relevant concentration of arsenic trioxide and humic acid promoted tumor progression of human cervical cancer cells: In vivo and in vitro studies. | 2016 Sep |
1 |
| 13 |
26274316 | VEGFA Expression Is Inhibited by Arsenic Trioxide in HUVECs through the Upregulation of Ets-2 and miRNA-126. | 2015 |
5 |
| 14 |
25088040 | Arsenic trioxide exerts anti-lung cancer activity by inhibiting angiogenesis. | 2014 |
1 |
| 15 |
24129092 | VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia. | 2013 Nov |
2 |
| 16 |
22664115 | Targeted inhibition of VEGF-modulated survival and arsenic sensitivity in acute myeloid leukemia (AML). | 2012 May |
2 |
| 17 |
22931643 | [Effects of hyperbaric oxygenation combined with As(2)O(3) on proliferation of K562 cells and associated mechanism]. | 2012 Aug |
1 |
| 18 |
21035354 | VEGF targeted therapy in acute myeloid leukemia. | 2011 Nov |
1 |
| 19 |
21473291 | Arsenic trioxide induces apoptosis of Burkitt lymphoma cell lines through multiple apoptotic pathways and triggers antiangiogenesis. | 2011 |
1 |
| 20 |
20435036 | Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth. | 2010 Aug 1 |
1 |
| 21 |
22966360 | Effect of thalidomide and arsenic trioxide on the release of tumor necrosis factor-α and vascular endothelial growth factor from the KG-1a human acute myelogenous leukemia cell line. | 2010 Jul |
2 |
| 22 |
17650671 | [Effect of arsenic trioxide on VEGF/R and MMP-2, 9 expressed in K562 cells]. | 2007 Feb |
4 |
| 23 |
17997939 | [Effects of arsenic trioxide on expressions of vascular endothelial growth factor and P-glycoprotein in multidrug resistant leukemia cell line K562/A02]. | 2007 Nov |
7 |
| 24 |
18161919 | Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice. | 2007 Dec 28 |
1 |
| 25 |
16638192 | [Effect of arsenic trioxide on bone marrow stromal cells of patients with multiple myeloma]. | 2006 Apr |
2 |
| 26 |
16928304 | [Inhibited proliferation of B-lymphoma Raji cells and down-regulated expression of VEGF by arsenic trioxide]. | 2006 Aug |
2 |
| 27 |
15723287 | Diarsenic and tetraarsenic oxide inhibit cell cycle progression and bFGF- and VEGF-induced proliferation of human endothelial cells. | 2005 May 1 |
1 |
| 28 |
15949266 | [Effects of dexamethasone on arsenic trioxide induced apoptosis, NF-kappaB activation and gene expression in lymphoma cell line]. | 2005 Apr |
2 |
| 29 |
16277838 | [Arsenic trioxide induced leukemic cell apoptosis relative to NF-kappaB activation]. | 2005 Oct |
4 |
| 30 |
12844409 | [Down-regulation of expression of vascular endothelial growth factor induced by arsenic trioxide in bone marrow cells of chronic myeloid leukemia]. | 2003 Jun |
3 |
| 31 |
12492118 | Arsenic trioxide inhibits growth of human multiple myeloma cells in the bone marrow microenvironment. | 2002 Aug |
1 |
| 32 |
10942401 | Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. | 2000 Aug 15 |
1 |